Mead Johnson Nutrition CO (MJN) Position Boosted by BNP Paribas Arbitrage SA

BNP Paribas Arbitrage SA raised its stake in Mead Johnson Nutrition CO (NYSE:MJN) by 236.5% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 195,587 shares of the company’s stock after buying an additional 137,468 shares during the period. BNP Paribas Arbitrage SA owned about 0.10% of Mead Johnson Nutrition CO worth $17,423,000 at the end of the most recent reporting period.

A number of other large investors have also bought and sold shares of the company. Marathon Asset Management LLP increased its position in shares of Mead Johnson Nutrition CO by 18.7% in the third quarter. Marathon Asset Management LLP now owns 617,303 shares of the company’s stock valued at $48,989,000 after buying an additional 97,221 shares in the last quarter. Emerald Acquisition Ltd. increased its position in shares of Mead Johnson Nutrition CO by 50.0% in the third quarter. Emerald Acquisition Ltd. now owns 199,563 shares of the company’s stock worth $15,767,000 after buying an additional 66,550 shares during the period. Two Sigma Advisers LP increased its position in shares of Mead Johnson Nutrition CO by 12.6% in the third quarter. Two Sigma Advisers LP now owns 473,190 shares of the company’s stock worth $37,387,000 after buying an additional 53,100 shares during the period. Kentucky Retirement Systems bought a new position in shares of Mead Johnson Nutrition CO during the fourth quarter worth $948,000. Finally, Nordea Investment Management AB increased its position in shares of Mead Johnson Nutrition CO by 17.9% in the third quarter. Nordea Investment Management AB now owns 719,315 shares of the company’s stock worth $56,833,000 after buying an additional 109,400 shares during the period. 95.36% of the stock is currently owned by institutional investors and hedge funds.

Institutional Ownership by Quarter for Mead Johnson Nutrition CO (NYSE:MJN)

Mead Johnson Nutrition CO (NYSE:MJN) traded up 0.03% during midday trading on Friday, hitting $89.00. 1,785,515 shares of the stock traded hands. The stock has a 50-day moving average of $88.93 and a 200 day moving average of $80.71. The firm has a market cap of $16.34 billion, a PE ratio of 27.96 and a beta of 1.38. Mead Johnson Nutrition CO has a 52-week low of $69.25 and a 52-week high of $94.40.

Mead Johnson Nutrition CO (NYSE:MJN) last announced its quarterly earnings results on Thursday, April 27th. The company reported $0.80 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $0.79 by $0.01. The company had revenue of $883.50 million for the quarter, compared to analyst estimates of $911.63 million. Mead Johnson Nutrition CO had a net margin of 14.56% and a negative return on equity of 125.35%. The firm’s revenue was down 8.2% on a year-over-year basis. During the same period in the prior year, the firm posted $0.87 earnings per share. Equities analysts forecast that Mead Johnson Nutrition CO will post $3.16 EPS for the current year.

WARNING: “Mead Johnson Nutrition CO (MJN) Position Boosted by BNP Paribas Arbitrage SA” was published by Chaffey Breeze and is the sole property of of Chaffey Breeze. If you are viewing this article on another website, it was illegally stolen and reposted in violation of US & international copyright law. The legal version of this article can be viewed at https://www.chaffeybreeze.com/2017/05/19/bnp-paribas-arbitrage-sa-has-17-423-million-stake-in-mead-johnson-nutrition-co-mjn-updated.html.

A number of analysts have commented on MJN shares. Credit Suisse Group AG cut shares of Mead Johnson Nutrition CO from an “outperform” rating to a “neutral” rating and set a $90.00 target price for the company. in a report on Sunday, March 5th. Zacks Investment Research cut shares of Mead Johnson Nutrition CO from a “hold” rating to a “sell” rating in a report on Friday, April 28th. Berenberg Bank raised shares of Mead Johnson Nutrition CO from a “sell” rating to a “hold” rating and set a $66.00 target price for the company in a report on Thursday, February 2nd. Citigroup Inc cut shares of Mead Johnson Nutrition CO from a “buy” rating to a “neutral” rating in a research note on Monday, March 6th. Finally, BMO Capital Markets cut shares of Mead Johnson Nutrition CO from an “outperform” rating to a “market perform” rating and increased their price objective for the stock from $84.00 to $90.00 in a research note on Friday, February 10th. Two research analysts have rated the stock with a sell rating and twelve have assigned a hold rating to the company’s stock. The company has a consensus rating of “Hold” and an average price target of $84.83.

Mead Johnson Nutrition CO Company Profile

Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children’s nutrition and other nutritional products. The Company operates through three segments: Asia, Latin America and North America/Europe. Its product portfolio includes routine and specialty infant formulas, children’s milks and milk modifiers, dietary supplements for pregnant and breastfeeding mothers, pediatric vitamins, and products for pediatric metabolic disorders.

5 Day Chart for NYSE:MJN

Receive News & Ratings for Mead Johnson Nutrition CO Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mead Johnson Nutrition CO and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply